Taking people in Magyarország4. fázis
BudapestICIVasc: Cardiovascular side effects of immune checkpoint inhibitor oncological therapies and their monitoring in the context of onco-cardiology
Key facts
- Where
- Budapest VIII, MagyarországSee the site
- Phase
- 4. fázis
Where in Magyarország
- Semmelweis UniversityBudapest VIII, MagyarországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Semmelweis University
- Trial code
- EU 2025-523620-44-02
- Record updated
- 2026. január 14.
- Original description
In this study, we aim to investigate the cardiovascular side effects of immune checkpoint inhibitors.Read full original descriptionShow less
In this study, we aim to investigate the cardiovascular side effects of immune checkpoint inhibitors.
Inclusion: Patients presented to the oncology teams of Semmelweis University and clinics in the country wishing to join the research; Planned immune checkpoint inhibitor therapy; At least 18 years of age; Signing of the patient information sheet and consent form by the patient; Accessible medical history.
Exclusion: Age under 18; Lack of informed consent form; Illiteracy; Pregnancy and breastfeeding.